Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes (PPROM)

NCT04100252 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT04100252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04100252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes (PPROM)
Lead sponsor
Istanbul Medeniyet University
Phase
Observational
Overall status
Completed
Start date
September 1, 2018
Completion date
September 1, 2019
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amniotic fluid leakage, fetal complications, maternal complication of pregnancy, premature rupture of membrane